Savvy Psychopharmacology

Herb–drug interactions: Caution patients when changing supplements

Author and Disclosure Information

 

References

Ms. X, age 41, has a history of bipolar disorder and presents with extreme sleepiness, constipation with mild abdominal cramping, occasional dizziness, and “palpitations.” Although usually she is quite articulate, Ms. X seems to have trouble describing her symptoms and reports that they have been worsening over 4 to 6 days. She is worried because she is making mistakes at work and repeatedly misunderstanding directions.

Ms. X has a family history of hyperlipidemia, heart disease, and diabetes, and she has been employing a healthy diet, exercise, and use of supplements for cardiovascular health since her early 20s. Her medication regimen includes lithium, 600 mg, twice a day, quetiapine, 1,200 mg/d, a multivitamin and mineral tablet once a day, a brand name garlic supplement (garlic powder, 300 mg, vitamin C, 80 mg, vitamin E, 20 IU, vitamin A, 2,640 IU) twice a day, and fish oil, 2 g/d, at bedtime. Lithium levels consistently have been 0.8 to 0.9 mEq/L for the last 3 years.

Ms. X describes no changes in her diet or prescription medications, but mentions that the brand name garlic supplement she takes was out of stock early last week, so she bought another brand of garlic supplement, consisting of oil capsules. Ms. X says, “I made sure the dose was exactly the same, since you told me not to change doses without checking with you first!” You review the bottle she brought with her and see that it contains garlic oil with “allicin equivalent to 300 mg of garlic powder” and 60 mg of vitamin C with rose hips, vitamin E, 20 IU, vitamin A, 2,200 IU, and piperine, 20 mg.

Factors of drug–supplement interactions

Because an interaction is possible doesn’t always mean that a drug and an offending botanical cannot be used together. With awareness and planning, possible interactions can be safely managed (Table 1). Such was the case of Ms. X, who was stable on a higher-than-usual dosage of quetiapine (average target is 600 mg/d for bipolar disorder) because of presumed moderate enzyme induction by the brand name garlic supplement. Ms. X did not want to stop taking this supplement when she started quetiapine. Although garlic is listed as a possible moderate cytochrome P450 (CYP) 3A4 inducer, there is conflicting evidence.1 Ms. X’s clinician advised her to avoid changes in dosage, because it could affect her quetiapine levels. However, the change in the botanical preparation from dried, powdered garlic to garlic oil likely removed the CYP3A4 enzyme induction, leading to a lower rate of metabolism and accumulation of the drug to toxic levels.


Pages

Recommended Reading

Differentiating ADHD and bipolar disorder
MDedge Psychiatry
Revisiting delirious mania; Correcting an error
MDedge Psychiatry
Depression in pediatric bipolar disorder
MDedge Psychiatry
Lower BDNF levels found in older adults with bipolar I
MDedge Psychiatry
Pills to powder: An updated clinician’s reference for crushable psychotropics
MDedge Psychiatry
SSRI activation in children, adolescents often misdiagnosed as bipolar
MDedge Psychiatry
Treating psychopathology in developmentally disabled tricky
MDedge Psychiatry
Minimizing use of antipsychotics
MDedge Psychiatry
Is your patient’s valproic acid dosage too low or high? Adjust it with this equation
MDedge Psychiatry
Psychological account of Robert Lowell’s life is magnificent
MDedge Psychiatry